| Description | Zymosan A, derived from Saccharomyces cerevisiae, is a TLR2 agonist and exhibits significant radioprotective effects, mitigating and preventing IR-induced intestinal injury in mice. Furthermore, Zymosan A aids in the regeneration of intestinal stem cells (ISCs) following IR injury [1]. |
| In vivo | Zymosan A 适用于动物模型建立，用于构筑小鼠的腹膜炎模型。通过腹腔注射Zymosan A（25.0 mg/kg；于IR胁迫前12小时及2小时）可缓解IR诱导的小鼠肠损伤[1]。 |
| Synonyms | Zymosan A from Saccharomyces cerevisiae |
| molecular weight | N/A |
| CAS | 58856-93-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |